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Detection of autoreactive CD4 T cells using major
histocompatibility complex class II dextramers
Chandirasegaran Massilamany3, Bijaya Upadhyaya3, Arunakumar Gangaplara3, Charles Kuszynski1,2 and
Jay Reddy2,3*
Abstract
Background: Tetramers are useful tools to enumerate the frequencies of antigen-specific T cells. However, unlike
CD8 T cells, CD4 T cells - especially self-reactive cells - are challenging to detect with major histocompatibility
complex (MHC) class II tetramers because of low frequencies and low affinities of their T cell receptors to MHC-
peptide complexes. Here, we report the use of fluorescent multimers, designated MHC dextramers that contain a
large number of peptide-MHC complexes per reagent.
Results: The utility of MHC dextramers was evaluated in three autoimmune disease models: 1) proteolipid protein
(PLP) 139-151-induced experimental autoimmune encephalomyelitis in SJL/J (H-2s) mice; 2) myelin oligodendrocyte
glycoprotein (MOG) 35-55-induced experimental autoimmune encephalomyelitis in C57Bl/6 (H-2b) mice; and 3)
cardiac myosin heavy chain (Myhc)-a 334-352-induced experimental autoimmune myocarditis in A/J (H-2a) mice.
Flow cytometrically, we demonstrate that IAs/PLP 139-151, IAb/MOG 35-55 and IAk/Myhc-a 334-352 dextramers
detect the antigen-sensitized cells with specificity, and with a detection sensitivity significantly higher than that
achieved with conventional tetramers. Furthermore, we show that binding of dextramers, but not tetramers, is less
dependent on the activation status of cells, permitting enumeration of antigen-specific cells ex vivo.
Conclusions: The data suggest that MHC dextramers are useful tools to track the generation and functionalities of
self-reactive CD4 cells in various experimental systems.
Keywords: Antigen-specific CD4 cells, Central nervous system, Dextramers, Experimental autoimmune encephalo-
myelitis, Experimental autoimmune myocarditis, Heart, Major histocompatibility complex class II, Myelin oligoden-
drocyte glycoprotein, Cardiac myosin heavy chain-alpha, Proteolipid protein, Tetramers
Background
Traditionally, limiting dilution analysis and cytokine ELI-
SPOT assays have been used to enumerate the frequen-
cies of antigen-specific cells, but low specificity and the
tedious nature of these assays limit their use for routine
applications [1-3]. To overcome these limitations, tetra-
mer technology has been developed [4]. This approach
involves derivation of fluorescent dye-labeled tetramer-
ized complexes containing peptide-assembled major his-
tocompatibility complex (MHC) molecules. The use of
tetramers permits easy and rapid detection of antigen-
sensitized T cells at a single cell level by flow cytometry
(FC) [4,5]. Additionally, tetramer reagents can be used in
conjunction with antibodies to phenotypically character-
ize the generation and expansion of antigen-specific cells
during ensuing immune responses and to study their
functionalities by cell sorting.
Unlike with MHC class I tetramers, direct enumeration
of antigen-specific cells - in particular, rare and low-affinity
autoreactive CD4 T cells - with MHC class II tetramers
has been difficult. Under natural conditions, interaction
between T cells and antigen-presenting cells involves
engagement of MHC molecules with multiple T cell recep-
tors (TCRs), but their binding strength is low. Hence, their
stability requires interaction between various adhesion
molecules. Tetramers are artificially created peptide-
assembled MHC complexes, and their interactions with
TCRs occur in the absence of accessory molecules, a
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limitation that exists with both class I and class II tetra-
mers. In spite of this limitation, class I tetramers can gener-
ally bind CD8 T cells, but require participation of a CD8
coreceptor [6]. By comparison, participation of a CD4 core-
ceptor is not critical for class II tetramers to bind to CD4
cells [7,8]. This differential requirement of coreceptors
may, in part, explain differences in the abilities of tetramers
to bind respective T cell populations.
It is generally accepted that class II tetramers preferen-
tially bind activated CD4 cells expressing high amounts
of CD4 and CD25 [9-12]. We and others had previously
proposed that activation might result in reorientation
and configuration of TCR and accessory molecules, lead-
ing to enhanced avidity of TCR-MHC binding [11,13,14],
thus restricting the utility of the reagents for direct enu-
meration of the frequencies of antigen-sensitized cells ex
vivo. Recently, MHC dextramers bearing dextran back-
bones assembled with peptide-tethered MHC class I
molecules have been shown to detect antigen-specific
CD8 T cells [15,16]. Our studies involve the use of a
streptavidin (SA)-dextramer conjugate of 270 kDa, which
has been validated to detect tumor- and virus-specific
cells in various systems [15,17-19]. To address the utility
of dextramers, we used three autoimmune disease mod-
els: 1) proteolipid protein (PLP) 139-151-induced experi-
mental autoimmune encephalomyelitis (EAE) in SJL/J
(H-2s) mice; 2) myelin oligodendrocyte glycoprotein
(MOG) 35-55-induced EAE in C57Bl/6 (H-2b) mice; and
3) cardiac myosin heavy chain (Myhc)-a 334-352-
induced experimental autoimmune myocarditis (EAM) in
A/J (H-2a) mice. We demonstrated that MHC class II
dextramers detect self-reactive CD4 T cells with specifi-
city and to a greater sensitivity than conventional tetra-
mers. We showed that binding of dextramers, but not
tetramers, is less dependent on activation status of the
cells, thus permitting the reagents to determine the fre-
quencies of antigen-specific cells ex vivo in immunized
mice.
Methods
Mice
Four-to-six-week-old female SJL/J (H-2s) and C57Bl/6 (H-
2b) mice and six-to-eight-week-old A/J (H-2a) mice were
procured from the Jackson Laboratory (Bar Harbor, ME).
The mice were maintained according to the animal proto-
col guidelines of the University of Nebraska-Lincoln,
Lincoln, NE.
Peptide synthesis and immunization procedures
PLP 139-151 (HSLGKWLGHPDKF), MOG 35-55
(MEVGWYRSPFSRVVHLYRNGK) and Myhc-a 334-352
(DSAFDVLSFTAEEKAGVYK) were synthesized on 9-
fluorenylmethyloxycarbonyl chemistry (Neopeptide,
Cambridge, MA). All peptides were HPLC-purified
(>90%), identity was confirmed by mass spectroscopy, and
the peptides were dissolved in 1 × PBS prior to use. To
generate primary T cell cultures for PLP 139-151 and
MOG 35-55, SJL and C57Bl/6 mice, respectively, were
immunized with the above peptides emulsified in com-
plete Freund’s adjuvant (CFA) subcutaneously (s.c.) in
multiple sites in the flank and sternal regions (100 μg/
mouse) [5,20]. For immunization of A/J mice with Myhc-
a 334-352, the peptide was emulsified in CFA supplemen-
ted with Mycobacterium tuberculosis (M. tb; Difco Labora-
tories, Detroit, MI) extract to a final concentration of 5
mg/ml and injected s.c. in the flank, foot pads and sternal
regions (100 μg/mouse). For disease induction, however,
regardless of peptides used, emulsions were prepared in
CFA containing M. tb extract to a final concentration of 5
mg/ml. To induce EAE with PLP 139-151 or MOG 35-55,
peptide emulsions were given as a single dose [11,20],
whereas for EAM induction, two doses of emulsions con-
taining Myhc-a 334-352 were administered with an inter-
val of one week [21,22]. Nonetheless, all animals involved
in the disease-induced protocols received pertussis toxin
(List Biological Laboratories, Campbell, CA) intraperitone-
ally on day 0 and day 2 after the first immunization (PLP
139-151 and Myhc-a 334-352, 100 ng/mouse; MOG 35-
55, 200 ng/mouse) [5,20,21]. SJL and C57Bl/6 mice were
monitored for the appearance of clinical signs of EAE and
scored as described [23,24]: 0 - healthy; 1 - limp tail or
hind limb weakness but not both; 2 - limp tail and hind
limb weakness; 3 - partial paralysis of hind limbs; 4 - com-
plete paralysis of hind limbs; 5 - moribund or dead.
Generation of antigen-specific primary T cell cultures
Ten days after immunizations with peptides, mice were
sacrificed, and the maxillary, mandibular, axillary, ingu-
inal and popliteal draining lymph nodes (LN) were col-
lected. Single cell suspensions were prepared after lysing
the erythrocytes with 1 × ammonium chloride potas-
sium buffer (Lonza, Walkersville, MD). Lymph node
cells (LNC) were stimulated with the peptides (PLP 139-
151, 20 μg/ml; MOG 35-55 and Myhc-a 334-352, 50
μg/ml) at a density of 5 × 106 cells/ml for two days in
RPMI medium supplemented with 10% fetal bovine
serum (FBS), 1 mM sodium pyruvate, 4 mM L-gluta-
mine, 1 × each of non-essential amino acids and vitamin
mixture, 100 U/ml penicillin-streptomycin and 50 μg/ml
gentamicin (Lonza). After two days, cultures were sup-
plemented with the above medium containing interleu-
kin (IL)-2 (eBioscience, San Diego, CA), hereafter
termed growth medium. Viable lymphoblasts were har-
vested two to three days later by Ficoll-Hypaque density
gradient centrifugation, and the cultures were main-
tained in growth medium.
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Isolation of mononuclear cells (MNC) from CNS tissues
and hearts
After euthanization, mice were perfused by injecting 10 ml
of 1 × cold PBS into the left ventricle of the hearts; brains
were harvested by blunt dissection; and spinal cords were
flushed out using 1 × cold PBS. The tissues were homoge-
nized and digested with type IV collagenase (400 U/ml;
Worthington, Lakewood, NJ) at 37°C for 1 hour, and
MNC were harvested by percoll density gradient centrifu-
gation (70%/30%) as described previously [25]. To harvest
MNC from hearts, animals were first perfused as above,
and hearts were collected and minced. The tissue suspen-
sions were then incubated with a buffer containing 1 ×
PBS, collagenase and 2% FBS at 37°C for 15 min in a sha-
ker with continuous agitation. The digested tissues were
passed through an 18G needle and incubated for an addi-
tional 10 minutes; the cell pellets were obtained by centri-
fugation and resuspended in 40% buffered percoll. Cell
suspensions were overlaid with 75% percoll and centri-
fuged; the interphase representing MNC was then
collected and washed [26,27].
Derivation of IAs, IAb and IAk tetramers and dextramers
IAs/PLP 139-151 and IAs/Theiler’s murine encephalo-
myelitis virus (TMEV) viral capsid protein2 70-86, IA
b/
MOG 35-55, and IAk/Myhc-a 334-352 and IAk/Bovine
ribonuclease (RNase) 43-56 tetramers were generated as
previously described [5,11,25,28]. While we generated the
IAk constructs [11,29], the IAs and IAb constructs were
kindly gifted by Dr. Vijay Kuchroo, Harvard University,
Boston, MA. Briefly, a and b constructs for each IA allele
containing the sequences of the respective peptides were
expressed in a Baculovirus system using Sf9 insect cells
(Invitrogen, Carlsbad, CA) and soluble MHC molecules
were obtained [5,11]. IAs, IAb and IAk monomers were
purified on antibody columns prepared using MKS4,
M5114, and 10-2.16 (Bio × Cell, West Lebanon, NH),
respectively and the protein yield generally ranged from
0.5 mg to 1 mg/L [5,11,25,28]. After concentrating, the
soluble MHC proteins were biotinylated using biotin pro-
tein ligase at an optimized concentration of 25 μg/10
nmol of substrate as recommended by the manufacturer
(Avidity, Denver, CO). The biotinylated proteins were
then incubated with SA conjugated with a fluorescent
dye - fluorescein isothiocyanate (FITC), phycoerythrin
(PE) or allophycocyanin (APC) - at a 4:1 ratio for one
hour on ice. The reagents thus prepared are referred to
as tetramers. To prepare dextramers, biotinylated soluble
monomers of all three IA alleles (IAs, IAb and IAk) con-
taining the peptides were coupled to activated dextran
backbones (kindly provided by Immudex Aps, Copenha-
gen, Denmark) at various molar ratios in 1 × Tris Hcl
0.05 M, pH 7.2 for 30 minutes at room temperature (RT)
and the preparation of fluorochrome-labeled dextran
backbone has been previously described [16]. Fluoro-
chrome-labeled dextramers were prepared by mixing
biotinylated IA monomers with dextran molecules. For
example, dextramer-PE reagents were prepared by mix-
ing 1.6 × 10-11 moles of dextran-PE molecules with
3.17 × 10-10 moles of IAs monomers which resulted a
molar ratio of 1:20. All the reagents were aliquoted and
stored at -80°C or 4°C until further use.
Tetramer or dextramer staining
(a) Cells activated in vitro
To enumerate the frequencies of tetramer (tet+) or dextra-
mer (dext+) cells, viable lymphoblasts harvested from cul-
tures prepared from immunized SJL, C57Bl/6 or A/J mice
were used for tet or dext staining as described previously
[5,30]. Briefly, cells were stained with tetramers or dextra-
mers in growth medium, pH 7.6, containing 2.5% FBS at
RT for up to 3 hours, followed by staining with anti-CD4
(eBioscience, San Diego, CA) and 7-aminoactinomycin D
(7-AAD; Invitrogen). After washing, cells were analyzed by
flow cytometry (FC; FACSCalibur, BD Biosciences, San
Diego, CA). Percentages of tet+ or dext+ cells were then
determined in the live (7-AAD-) CD4 subset using Flow Jo
software (Tree Star, Ashland, OR). In some experiments,
antigen-sensitized cells were rested for two weeks in
growth medium and treated with or without neuramini-
dase (NASE) (0.7 U/ml) (Type X from Clostridium perfrin-
gens; Sigma-Aldrich, St. Louis, MO) prior to tet or dext
staining [11].
(b) Ex vivo staining
LNC were obtained from a pool of draining LN harvested
from groups of mice immunized with various peptides.
CD4 cells were enriched from LNC to a purity of more
than 95% by negative selection based on magnetic separa-
tion using IMAG as recommended by the manufacturer
(BD Biosciences). After treating the cells with or without
NASE as above, cells were washed in 5 ml of 1 × PBS;
incubated with tetramers or dextramers for two hours at
RT in growth medium, pH 7.6, containing FBS (2.5%).
Cells were washed twice with 5 ml of 1 × PBS and stained
with anti-CD4, anti-CD25, anti-CD44 (all from
eBioscience) and 7-AAD and analyzed by FC. The percen-
tages of tet+ or dext+ cells were determined in the live
(7-AAD-) cells corresponding to CD4, CD25 and CD44
subsets. To stain MNC obtained from CNS tissues, cells
were incubated with tetramers or dextramers directly
without NASE treatment, and the percentages of tet+ or
dext+ cells were determined as described above.
Sorting of tet+ or dext+ cells by flow cytometry
LNC isolated from immunized mice were stimulated with
PLP 139-151 at a density of 5 × 106 cells/ml and viable
lymphoblasts were harvested on day 6 poststimulation
and stained with tetramers or dextramers for two hours
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at RT. After washing, cells were stained with anti-CD4
and 7-AAD; the tet-CD4+ and dext-CD4+ cells were
sorted by FC (FACSAria, BD Biosciences, San Jose, CA),
and each fraction was divided into two aliquots. One ali-
quot of cells was immediately stained with APC-labeled
PLP 139-151 or control dextramers for two hours, fol-
lowed by 7-AAD. After acquiring the data by FC, dext+
cells were analyzed in the live (7-AAD-) subset. The sec-
ond aliquot (0.75 × 106 cells/ml) was rested in growth
medium for two weeks and stimulated with PLP 139-151
(10 μg/ml) in the presence of irradiated antigen-present-
ing cells for two days; growth medium was then supple-
mented. Viable lymphoblasts were harvested two days
later, and on day 6 poststimulation, PLP 139-151 or con-
trol tet or dext staining was performed followed by anti-
CD4 and 7-AAD and the percentages of live tet+ or dext+
cells were enumerated as above.
Statistics
Differences between specific and control tet or dext and
also between the groups were analyzed by student’s t.
P ≤ 0.05 values were considered significant.
Results
Optimization of reaction conditions for dextramer
staining
We optimized reaction conditions for dext staining
using IAs/PLP 139-151 dextramers, and in all reactions,
TMEV 70-86 dextramers were used as controls. Dextra-
mers were prepared using a PE-conjugated dextran poly-
mer backbone carrying SA moieties. Each SA moiety
can bind three biotinylated peptide-tethered IAs mole-
cules, whereas the fourth moiety appears not available
for binding due to steric hindrance [16]. The mixture of
both yielded a molar ratio of 1:20 between dextrans and
IAs monomers. For optimization, we prepared a series
of molar ratios ranging from 60:1 to 1:60 and used them
to stain PLP 139-151-reactive T cells by FC (Figure 1).
The staining intensity obtained with dextramers was
then compared with that of PLP 139-151 tetramers, and
all reactions were performed in growth medium at RT
for three hours. Figure 1 shows that PLP 139-151 dex-
tramers prepared at all ratios stained PLP-reactive cells,
and the staining was specific, since TMEV 70-86 dextra-
mers did not show any non-specific binding. Expectedly,
stimulation with PLP 139-151 resulted in two subsets of
CD4 cells namely CD4high and CD4low and elevated
CD4 expression identifies an activated and proliferating
subset of cells [10,12]. We and others had previously
shown that tetramers bind preferentially CD4high subset
[9-12]. Similar to tetramer staining, we also noted that
dextramers bind CD4high subset suggesting that both
tetramers and dextramers stain the same subset of CD4
cells in which antigen-sensitized cells are enriched
(Figure 1). The peak binding of dextramer occurred at a
molar ratio of 1:20, at which dextramers detected an
approximately 4-fold higher number of PLP-reactive
cells than did tetramers (2.59% vs. 0.68%; p = 0.047).
Therefore, we chose 1:20 molar ratio as the optimal
concentration for dext staining. Importantly, by estimat-
ing the amount of protein required to make tetramers
or dextramers, we noted that 1:20 molar ratio of dext
preparation required 0.43 μg of IAs protein per reaction,
as opposed to 0.9 μg of protein required for tetramers,
an ~2-fold difference. By evaluating the duration
required to achieve maximum staining intensity, we
noted that dextramers detected ~2- to 3-fold higher
numbers of cells than did tetramers at all time-points
tested (0.5 to 3 hours) (Figure 2A). The mid time-point
of 2 hours was chosen for subsequent experiments since
the staining intensity had nearly plateaued by then for
both dextramers and tetramers. Additionally, by titrating
the amount of dextramers required per reaction, we
chose a dose of 1:20 molar ratio (1x) for subsequent
analyses to conserve the reagent, although the staining
intensity obtained by doubling the amount of dextra-
mers tended to be high (Figure 2B). We then asked
whether repeated freezing and thawing would affect dex-
tramer binding. To address this question, we repeatedly
froze and thawed tetramers and dextramers up to six
cycles by freezing the reagents intermittently for a mini-
mum duration of 30 minutes at -80°C. These reagents
were used to stain PLP-reactive cells and, as shown in
Figure 2C, even though the staining intensity was main-
tained for both dextramers and tetramers suggesting
their tolerance to temperature fluctuations during sto-
rage, dextramers consistently detected higher number of
antigen-specific cells than with tetramers regardless of
freeze-thaw cycle number (~3.5% vs. 0.5%). Likewise, by
optimizing the cell numbers required for dext staining,
we noted that reactions containing cells ranging in num-
ber from 0.25 × 106 to 2 × 106 resulted in comparable
binding, but thereafter, the staining intensity tended to
be reduced (Figure 2D). Taken together, the data sug-
gest that MHC dextramers detect a significantly higher
proportion of antigen-reactive cells with specificity; their
derivation requires less IAs starting material; and the
staining can be achieved in shorter time intervals than
tetramers.
FITC-labeled dextramers but not tetramers detect
antigen-reactive cells
Among various fluorescent dyes, fluorescent signals gen-
erated from FITC are weak and hence FITC-labeled tet-
ramers are not generally used. Given the fact that
dextramers contain more FITC moieties, we reasoned
that fluoresceinated dextramers might give signals
strong enough to detect antigen-reactive cells by FC.
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We examined this possibility by staining PLP-reactive
cells with FITC-labeled PLP 139-151 or control tetra-
mers and dextramers, and the percentages of cells posi-
tive for each were analyzed (Figure 3). Additionally,
their fluorescent intensities were compared with tetra-
mers or dextramers labeled with PE or APC. Expectedly,
FITC-labeled PLP 139-151 tetramers did not yield any
discernable signals that were indicative of their specifi-
city when compared with control (TMEV) tetramers
(1.12% vs. 1.09%; Figure 3, left panel). On the contrary,
PLP 139-151 dextramers labeled with FITC stained a
population of PLP-reactive CD4 cells (3.37%), and the
cells bound with control dextramers were negligible
(0.23%) proving that FITC-labeled dextramers could be
used to detect antigen-specific cells. Comparison of the
staining intensities of dextramers and tetramers labeled
with PE and APC revealed that PE- and APC-labeled
dextramers detected cell numbers ~six-fold higher than
those detected with tetramers (Figure 3, right panel).
Importantly, although marginally low, percentages of
cells positive for FITC-labeled dextramers (3.37%) were
comparable to those obtained with PE- (4.25%) and
APC-(4.40%) labeled dextramers (Figure 3). The data
demonstrate that, FITC can be used as a second-choice
fluorescent label next to other brightly fluoresced dyes
such as PE or APC to prepare dextramer reagents.
dextramers tetramers
PLP
139Ͳ151
Control
CD
4
60:1 40:1 20:1 1:1 1:20 1:40 1:60
Streptavidin-PE-conjugated dextran molecules:biotinylated IAs monomers (molar ratios)
Streptavidin-PE-conjugated dextran molecules: 
biotinylated IAs monomers (molar ratios)
Figure 1 Specificity and sensitivity of IAs/PLP 139-151 dextramers. PLP 139-151 and control dextramers were prepared at the indicated
molar ratios by mixing SA-conjugated dextran-PE molecules with biotinylated soluble IAs molecules containing the peptide sequence for PLP
139-151. The amount of IAs protein used in each of the indicated molar ratios was as follows: 60:1, 40:1, 20:1, 1:1 and 1:20, 0.43 μg; 1:40, 0.86 μg
and 1:60, 1.29 μg. To prepare tetramers, 0.9 μg of IAs protein containing PLP 139-151 or TMEV 70-86 was used. PLP-reactive cells were generated
from SJL mice immunized with PLP 139-151, and viable cells harvested on day 6 poststimulation were stained with dextramers or tetramers
followed by anti-CD4 and 7-AAD. After acquiring the cells by FC, percentages of dext+ or tet+ cells were enumerated in the live (7-AAD-) CD4
subset (top panel). In each FC plots, the upper left quadrants indicate CD4+ cells containing CD4high (upper) and CD4low (lower) subsets. The
mean ± SEM values representing three individual experiments are shown (bottom panel). Control, TMEV 70-86.
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In spite of high sensitivity, dextramers fail to detect all
antigen-reactive cells
One of the issues being debated with tetramers is
whether they can detect all of the antigen-reactive cells
[14]. Since the staining intensity obtained with PLP 139-
151 dextramers was higher than that obtained with tet-
ramers, we hypothesized that dextramers can potentially
bind all antigen-specific cells. To address this hypoth-
esis, we stained PLP-reactive cells with dextramers and
tetramers, and they detected ~2.4% and ~1% of cells,
respectively (Figure 4A). We next sorted PLP dext- and
PLP tet- populations by FC and divided these into two
fractions. One fraction was stained with PLP 139-151 or
control dextramers immediately after sorting, and
Number of cycles
(C) Freeze-thaw cycling
Number of cells/reaction x106
(D) Cell density
Hours
(A) Duration of staining (B) Amount of dextramers
Concentration
Figure 2 Optimization of reaction conditions for IAs/PLP 139-151 dextramer staining. (A) Duration of staining. PLP139-151-reactive cells
generated from immunized mice were stained with PE-labeled tetramers or dextramers for PLP 139-151 and their controls. After incubating for
indicated time-points, cells were stained with anti-CD4 and 7-AAD and acquired by FC; percentages of dext+ or tet+ cells were determined in
the live (7-AAD-) CD4 subset. (B) Amount of dextramers. PLP 139-151-reactive cells were stained with the indicated concentrations of PLP 139-
151 or control dextramers, and percentages of live dext+ cells were determined in CD4 subset as above. The amount of biotinylated IAs protein
present in the 4 x-concentration was 1.72 μg and the protein concentration was halved serially in the remaining dilutions as shown. (C) Freeze-
thaw cycling. PLP 139-151 or control tetramers and dextramers were thawed upto six times after freezing at -80°C for a minimum of half an
hour between cycles and the reagents were used to stain PLP-reactive cells as above. Percentages of tet+ or dext+ cells were evaluated in the
live CD4 subset. Control, TMEV 70-86. (D) Cell density. PLP 139-151 or control dextramers were used to stain PLP-reactive cells at the indicated
cell numbers as above, and the percentages of dext+ cells were evaluated in the live CD4 subset. Mean ± SEM values obtained from three
individual experiments each involving two mice are shown.
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frequencies were analyzed. Expectedly, PLP dextramers
stained 1% of PLP tet- cells and, together with the pro-
portion of cells originally stained with tetramers (1%),
constituted approximately the same number of cells
(2%) obtained with dextramers (~2.4%; Figure 4A). The
other fraction was rested in IL-2 medium, and two
weeks later, cells were stimulated with PLP 139-151
(10 μg/ml) in the presence of syngeneic antigen-present-
ing cells from SJL mice. Six days poststimulation, viable
lymphoblasts were stained with PLP or TMEV dextra-
mers, and their frequencies were determined. Contrary
to expectations, PLP dextramers stained cells derived
from both PLP tet- and PLP dext- populations, but the
number of dext+ cells was approximately 1.5-fold higher
in the PLP tet- subset than in the PLP dext- subset
(Figure 4B). The data indicate that dextramers detect
antigen-specific cells to a significantly higher proportion
than the conventional tetramers, but a fraction of anti-
gen-reactive cells can still escape from their detection.
Activation dependency is less stringent for dextramer
binding
A major limitation of tetramers is their activation
dependency in binding to T cells. We and others had
previously shown that treating the cells with anti-TCR b
or NASE prior to tet staining can enhance their binding
by activating the cells [11,31,32]. We and others had
earlier proposed that NASE might enhance adhesiveness
of tetramers to the TCRs either by removing sialic acid
from the cell surface, thereby reducing the net charge
[31,32], or by nonspecifically activating the cells [11,32].
To address whether the use of dextramers can overcome
the above limitation, we compared the staining
characteristics of tetramers and dextramers using PLP-
reactive cells generated from SJL mice immunized with
PLP 139-151. Briefly, LNC obtained from immunized
mice were stimulated with PLP 139-151 and rested in
IL-2 medium. Ten days later, cells were treated with or
without NASE followed by staining with tetramers or
dextramers. Predictably, only 0.26% of cells treated with-
out NASE were stained with tetramers, while 3.28% of
cells were stained with dextramers, an ~12-fold differ-
ence (Figure 5). The staining was specific because
TMEV tet- or TMEV dext-bound cells were negligible.
NASE treatment, however, enhanced the staining inten-
sity by ~2-fold, regardless of reagents used (tetramers:
0.26% vs. 0.51%; dextramers: 3.28% vs. 7.07%). The
results suggest that dextramers can bind rested antigen-
sensitized cells, and their detection sensitivity is higher
than that was achieved with tetramers.
Dextramers are useful tools to enumerate the frequencies
of antigen-specific cells ex vivo
After optimizing the conditions for dext staining, we
sought to evaluate the utility of using dextramers to
enumerate the frequencies of antigen-specific cells ex
vivo. CD4 cells enriched from immunized SJL mice were
treated with or without NASE prior to tet or dext stain-
ing, and the percentages of tet+ or dext+ cells were
determined in CD4, CD25 or CD44 subsets, where
CD25 and CD44 represent activation and memory T
cell markers, respectively. Figure 6A (top left panel)
demonstrates that PLP 139-151 tetramers detected a
minute fraction of PLP-reactive CD4 cells in the absence
of NASE treatment, and detection was barely improved
with NASE treatment (0.01% vs. 0.03%). On the
PLP 
139-151
Control
DextramersTetramers
FITC-labeled
tet-FITC dext-FITC
DextramersTetramers
PE-labeled
tet-PE dext-PE
C
D
4
DextramersTetramers
APC-labeled
tet-APC dext-APC
Figure 3 IAs/PLP 139-151 dextramers, but not tetramers, labeled with FITC are useful to detect antigen-specific cells. PLP-reactive cells
generated from SJL mice immunized with PLP 139-151 were stained with PLP 139-151 or control tetramers and dextramers, each labeled with
FITC, PE or APC, followed by anti-CD4 and 7-AAD. After acquiring the cells by FC, percentages of tet+ or dext+ cells were analyzed in the live (7-
AAD-) CD4 subset. Data from one of the two independent experiments each involving 2 mice are shown.
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Figure 4 In spite of high sensitivity, not all antigen-specific cells are detected by IAs/PLP 139-151 dextramers. (A) Pre-FC-sorting. PLP-
reactive cells generated from SJL mice immunized with PLP 139-151 were stained with PLP 139-151 or control tetramers or dextramers,
followed by anti-CD4 and 7-AAD. After analyzing the cells as negative or positive for tetramers and dextramers, tet- and dext- CD4 cells were
sorted by FC, and the cells were divided into two aliquots. One of these was immediately stained with PLP 139-151 and control dextramers, and
percentages of dext+ cells were evaluated in the live (7-AAD-) subset. (B) Post-FC-sorting. The second aliquot of tet- and dext- cells was rested
for two weeks and the cells were stimulated with PLP 139-151 in the presence of irradiated antigen-presenting cells; after two days, growth
medium was supplemented. Viable cells were harvested on day 6 poststimulation and stained with PLP 139-151 or control dextramers and anti-
CD4 and 7-AAD. After analyzing the cells by FC, dext+ and dext- cells were enumerated in the live CD4 subset. Control, TMEV 70-86. Data from
one of the two individual experiments each involving three mice are shown.
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contrary, PLP 139-151 dextramers convincingly stained
a proportion of cells expressing CD4, CD25 and CD44,
even without NASE treatment. By treating the cells with
NASE, the staining intensity could be increased by
approximately 2-fold (CD4: 0.04% vs. 0.12%; CD25:
0.28% vs. 0.81%; CD44: 0.39% vs. 1.04%; Figure 6A, top
right panel). In all these analyses, the antigen-specificity
of PLP dextramers was confirmed using control dextra-
mers (TMEV 70-86), whose binding was negligible. We
then asked whether dextramers can be used to stain
PLP 139-151-reactive effector cells that infiltrate CNS
tissues. MNC were harvested from brain and spinal
cords from mice showing partial hind limb paralysis,
which had scored 3 on day 12 postimmunization. The
cells were stained with tetramers or dextramers directly
with no NASE treatment, and the results were com-
pared (Figure 6B). The data revealed that while both tet-
ramers and dextramers stain the cells with specificity,
the proportion of cells stained with dextramers (2.17 ±
0.16) was ~3-fold higher than the proportion obtained
with tetramers (0.74 ± 0.09; p = 0.02) and the back-
ground staining for their corresponding controls was
low (0.56 ± 0.18 vs. 0.17 ± 0.07; p = 0.17). Overall, the
data indicated that the use of dextramers allows us to
enumerate the PLP-specific cells ex vivo, but their detec-
tion can be enhanced with NASE treatment.
We next determined the frequencies of antigen-sensi-
tized CD4 cells in two other disease models: MOG 35-55-
induced EAE in C57Bl/6 mice and Myhc-a 334-352-
induced EAM in A/J mice. We created tetramers and dex-
tramers for IAb/MOG 35-55 and IAk/Myhc-a 334-352.
First, we verified that the reagents stained antigen-sensi-
tized cells with specificity using peptide-stimulated LNC
cultures derived from mice immunized with MOG 35-55
or Myhc-a 334-352 (data not shown). Second, to enumer-
ate the frequencies of antigen-specific cells ex vivo, we
used CD4 cells enriched from immunized mice. In the
preliminary experiments, we confirmed that cells treated
without NASE could be stained with dextramers, but the
staining intensity was less distinct than in NASE-treated
cells. Therefore, we treated the cells with NASE followed
by tet or dext staining, and the cells positive for each were
analyzed flow cytometrically. We noted that MOG 35-55
dextramers detected 3- to 5-fold higher numbers of
MOG-reactive cells than MOG 35-55 tetramers, regardless
of the subsets analyzed (CD4: 0.40% vs. 0.11%; CD25: 1.
74% vs. 0.57%; CD44: 1.61% vs. 0.35%). The staining was
verified to be specific using PLP 139-151 tetramers or dex-
tramers as controls, and their background staining was
low (Figure 7A). We then performed staining on MNC
harvested from CNS tissues from MOG 35-55-induced
EAE in C57Bl/6 mice that had a score of 2 to 4. Cells were
stained with MOG 35-55 tetramers or dextramers without
exposing them to NASE. The analysis revealed that both
MOG 35-55 tetramers and dextramers stained a fraction
of cells, and the staining intensity was higher with dextra-
mers than with tetramers (1.81% vs. 0.44%, as opposed to
0.42% vs. 0.23% for their corresponding controls; Figure
7B). Likewise, we analyzed the frequencies of Myhc-a-
reactive cells ex vivo from immunized A/J mice using
Myhc-a 334-352 dextramers or tetramers in different sub-
sets, and the dext staining intensity was ~7 to 9-fold
Tetramers Dextramers
N
A
SE
 tr
ea
tm
en
t Ͳ
+
PLP 139-151 Control
tetramers
PLP 139-151 Control
dextramers
C
D
4
Figure 5 IAs/PLP 139-151 dextramers bind rested antigen-specific cells better than tetramers. PLP-reactive cells were generated from SJL
mice immunized with PLP 139-151, and were rested in growth medium for 10 days. Viable cells were harvested and stained with PLP 139-151
tetramers or dextramers after being treated with or without NASE. After washing, cells were stained with anti-CD4 and 7-AAD and acquired by
FC. Percentages of tet+ or dext+ live (7-AAD-) CD4 cells were then enumerated.
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higher than that achieved with tetramers (CD4: 0.21% vs.
0.03%; CD25: 1.26% vs. 0.16%; CD44: 1.02% vs. 0.11%;
Figure 8A). Although background staining with control
reagents (RNase 43-56) was significantly lower than with
Myhc-a tetramers or dextramers, the proportion of cells
stained with RNase dextramers tended to be high. To enu-
merate the frequencies of Myhc-a-specific cells in hearts
ex vivo, we used MNC harvested from hearts on day 21
postimmunization, and the cells were stained with Myhc-
a 334-352 or RNase 43-56 (control) tetramers or dextra-
mers. Figure 8B shows that while both Myhc-a tetramers
and dextramers stained a fraction of CD4 cells, Myhc-a
334-352 dextramers detected ~5-fold higher number of
Myhc-a-specific cells than with Myhc-a 334-352
tetramers (2.36% vs. 0.58%) and the background staining
for corresponding control reagents was low (0.38% vs.
0.31%). Taken together, the data demonstrate that dextra-
mers are useful tools to enumerate the precursor frequen-
cies of antigen-specific cells ex vivo and their detection
sensitivity is higher than that of tetramers.
Discussion
Using three different murine autoimmune disease mod-
els, we have demonstrated that MHC class II dextramers
permit ex vivo enumeration of self-reactive CD4 T cells
with specificity. Tetramers, but not monomers or
dimers, are useful in detecting CD4 T cells by FC
[4,12,33]. In spite of this technical advancement,
(B) MNC from CNS tissues
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4
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Tetramers
tetramers
dextramers
PLP 139-151 Control
(A) LNC
Dextramer staining
C
D
4
N
A
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t Ͳ
+
tetramers dextramers
Gate: CD25 Gate: CD44Gate: CD4
Tetramer staining:
PLP 139-151 Control ControlPLP 139-151 PLP 139-151 Control PLP 139-151 Control
Gated populations
Gate: CD4
Figure 6 IAs/PLP 139-151 dextramers detect PLP-specific cells ex vivo. (A) LNC. Groups of SJL mice were immunized with PLP 139-151 and
killed 10 days later; the draining LN were harvested to prepare single cell suspensions. CD4 cells were enriched from LNC by negative selection
based on magnetic bead separation. The cells were treated with or without NASE, followed by staining with PLP 139-151 or control tetramers or
dextramers, followed by a cocktail containing anti-CD4 and 7-AAD and anti-CD25 or anti-CD44. After tet+ and dext+ live cells (7-AAD-) cells were
acquired by FC, they were analyzed with respect to CD4, CD25 or CD44 subsets. Top panel shows representation of flow cytometric analysis,
whereas the lower left panel indicates mean ± SEM values obtained from five individual experiments each involving two mice. (B) MNC from
CNS tissues. Groups of three mice were immunized with PLP 139-151 in CFA to induce EAE, and animals showing paralytic signs were killed to
harvest brains and spinal cords. The tissues were processed to obtain MNC by percoll density-gradient separation, and the cells were stained
with PLP 139-151 or control tetramers or dextramers and anti-CD4 and 7-AAD. After acquiring the cells by FC, percentages of tet+ and dext+
cells were determined in the live CD4 population. Representative data from two individual experiments, each involving 2 to 3 mice, are shown.
Control, TMEV 70-86.
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detection of autoreactive CD4 cells is not straightfor-
ward because of their rarity in the peripheral repertoires,
and their detection often requires in vitro expansion
and/or enrichment [33]. In this scenario, however, while
antigen specificity of cells can still be confirmed, accu-
rate estimation of their frequencies can be prone to
error because of the need to activate cells prior to tetra-
mer staining. Structurally, dextramers contain dextran
backbones, which are polymers of glucose molecules
attached through 1-6 and 1-3 linkages [15]. Each dex-
tran molecule carries multiple moieties of SA to which
biotinylated peptide-tethered MHC molecules can be
assembled [15]. Therefore, MHC dextramers can yield
MHC-peptide complexes of large molecular weight,
allowing them to engage multiple TCRs - more than
that could be achieved with tetramers. To address this
hypothesis, we created MHC dextramers for three
mouse IA alleles, IAs, IAb and IAk for PLP 139-151,
MOG 35-55 and Myhc-a 334-352, respectively, and
showed that the reagents detect corresponding antigen-
sensitized cells with specificity and also to a higher sen-
sitivity than conventional tetramers.
Figure 7 Ex vivo detection of MOG-reactive cells by IAb/MOG 35-55 tetramers and dextramers. (A) LNC. CD4 cells were isolated from LNC
obtained from mice immunized with MOG 35-55; after treatment with NASE, cells were stained with MOG 35-55 or control tetramers or
dextramers, followed by staining with anti-CD4 and 7-AAD and anti-CD25 or anti-CD44. Cells were acquired by FC, and percentages of tet+ and
dext+ live (7-AAD-) cells were analyzed in CD4, CD25 and CD44 subsets. Upper and bottom left panels, respectively, represent FC plots and
mean ± SEM values obtained from three experiments each involving 3 to 5 mice. (B) MNC from CNS tissues. Groups of mice were immunized
with MOG 35-55 in CFA, and animals showing paralytic signs were killed and brain and spinal cords collected to harvest MNC by percoll density
gradient centrifugation. Cells were stained with MOG 35-55 or control tetramers and dextramers and anti-CD4 and 7-AAD. Cells were acquired
by FC and tet+ and dext+ cells were enumerated in the live CD4 subset. Representative data from three individual experiments, each involving 3
to 5 mice, are shown. Control, PLP 139-151.
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We optimized the conditions for dextramer staining
using PLP-reactive cells generated from SJL mice immu-
nized with PLP 139-151. Essentially, the conditions pre-
viously defined for conventional tetramers were also
optimum for dextramers, and the staining was per-
formed in growth medium supplemented with 2.5% FBS,
pH 7.6 [5,11]. However, we noted some important
advantages with dextramers, including enhanced sensi-
tivity, shortened staining duration and the ability to cre-
ate dextramers with a low amount of MHC/peptide
complexes. We found that dextramers prepared at a
1:20 molar ratio of SA-dextran molecules to biotinylated
MHC proteins were optimum to detect PLP-reactive
cells, and their detection sensitivity was ~4-fold higher
than that of tetramers. Importantly, the use of dextra-
mers allowed us to capture antigen-specific cells by FC
unambiguously as observed by an increase in their mean
fluorescent intensities in relation to tetramers (Figure 1).
This is an important consideration in flow cytometric
analysis, especially when FITC-labeled reagents are used.
In support of this notion, PLP 139-151 dextramers, but
not tetramers, labeled with FITC detect nearly equiva-
lent percentages of PLP-reactive cells similar to percen-
tages obtained with PE- or APC-labeled dextramers.
Figure 8 Ex vivo detection of Myhc-a-reactive cells by IAk/Myhc-a 334-352 tetramers and dextramers. (A) LNC. CD4 cells were isolated
from LNC harvested from immunized A/J mice and, after treatment with NASE, cells were stained with Myhc-a 334-352 or control tetramers and
dextramers, followed by anti-CD4 and 7-AAD and anti-CD25 or anti-CD44. After acquiring the cells by FC, percentages of tet+ and dext+ live (7-
AAD-) cells were determined in CD4, CD25 and CD44 subsets. Flow cytometric plots and mean ± SEM values obtained from four individual
experiments, each involving 3 to 5 mice, are depicted in top and bottom left panels, respectively. (B) MNC from hearts. Groups of A/J mice were
immunized with Myhc-a 334-352 and 21 days later, mice were sacrificed and hearts were collected to harvest MNC by percoll density gradient
centrifugation. After staining the cells with Myhc-a 334-352 or control tetramers or dextramers and anti-CD4 and 7-AAD, cells were acquired by
FC, and the percentages of tet+ and dext+ cells were enumerated in the live CD4 subset. Representative data from two individual experiments
each involving 7 mice, are shown. Control, RNase 43-56.
Massilamany et al. BMC Immunology 2011, 12:40
http://www.biomedcentral.com/1471-2172/12/40
Page 12 of 14
Furthermore, the enhanced detection of antigen-reactive
cells could be achieved as early as 30 minutes postincu-
bation with dextramers, whereas with tetramers, the
staining intensity was only marginally improved even
when extending the incubation time up to 3 hours. On
a reaction basis, we calculated the amount of MHC pro-
tein required to prepare tetramers to be 2- and 4-fold
higher than the amount of protein required to make
dextramers labeled with PE and APC, respectively. The
marginal reduction in the staining intensity obtained
with FITC-dextramers was expected because signals
generated from FITC are weaker than other fluorescent
dyes. The fact that FITC-labeled dextramers, but not
tetramers, bound PLP-reactive cells provides opportu-
nities to include this dye in the FC-based multicolor
analysis of antigen-specific T cell populations.
We believe that the higher detection sensitivity of dex-
tramers is due to the presence of multiple SA moieties,
allowing the formation of large clusters of MHC-peptide
complexes, which can interact with multiple TCRs, thus
enhancing the avidity of their interactions [15,33]. Conver-
sely, each tetramer molecule contains a single SA moiety
to which only up to four MHC-peptide complexes can
bind, limiting the availability of MHC-peptide complexes
to engage with multiple TCRs. As a result, tetramers
might bind T cells bearing high- but not low-affinity
TCRs. This appears to be the case because a proportion of
tet- cells sorted by FC could still be detected by dextra-
mers (Figure 4A). Nevertheless, it should be noted that
dextramers do not detect all antigen-sensitized cells, as
indicated by the fraction of PLP-reactive cells previously
negative for PLP dextramers that can become detectable
after a second restimulation with PLP 139-151 (Figure
4B). Presently the significance of these cell populations is
not known with respect to their TCR-affinities or func-
tionalities, such as cytokine synthesis or encephalitogeni-
city. Alternatively, failure to detect all antigen-reactive
cells with dextramers might be directly related to the den-
sity of TCRs expressed on the surface of T cells such that
low TCR-expressed cells may escape detection. From a
technical point of view, formation of stable MHC-peptide-
TCR interactions with dextramers can help cells withstand
harsh steps such as centrifugation and washing, thereby
enhancing specificity by minimizing the background stain-
ing. Overall, the fact that dextramers permit quick deter-
mination of antigen-specific cells with enhanced sensitivity
and because their creation requires less starting material,
they have proven to be superior to conventional tetramers.
One of the limitations of class II tetramer binding is
activation dependency [9-12]. Various strategies have been
employed to enhance the detection sensitivity of class II
tetramers by promoting interactions with multiple TCRs.
These include antibody-mediated TCR clustering, MHC-
peptide-coated liposomes and immunoglobulin molecules
[14,34-36]. We had previously shown that, upon resting,
antigen-sensitized cells that have expanded in vitro
become undetectable with tetramers, but can be detected
through NASE treatment prior to staining [11]. We asked
whether the use of dextramers can overcome as the need
for NASE treatment or activation. Expectedly, dextramers
could bind rested cells in the absence of NASE treatment
to a significantly greater proportion than that achieved
with tetramers (Figure 5). The data suggest that activation
dependency is not a critical factor for dextramer staining,
and we verified this phenomenon further by ex vivo enu-
meration of PLP-specific cells in SJL mice immunized
with PLP 139-151 (Figure 6). While, similar results were
obtained with IAb/MOG 35-55 and IAk/Myhc-a 334-352
dextramers, NASE treatment added the advantage of
enhancing their detection sensitivity as compared with tet-
ramers (Figures 7 and 8). The data prove that MHC dex-
tramers are useful tools for enumerating the frequencies
of antigen-specific T cells ex vivo in various experimental
systems.
Conclusion
We have shown that dextramers are superior to tetra-
mers in detecting autoreactive cells, which otherwise can
be technically challenging. While activation dependency
is less important for dextramer binding, detection sensi-
tivity can be enhanced by NASE treatment without com-
promising the specificity. Although dextramers cannot
detect all cells in spite of being antigen specific, their
greater detection sensitivity makes them first-choice
reagents over conventional tetramers. Additionally, the
inherent variation in the detection abilities of these
reagents is to be considered while interpreting the results
because frequencies of antigen-specific cells identified by
each reagent are expected to be different.
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